Changes to the summaries are made through a consensus process in which Board members evaluate the strength of the evidence in the published articles and determine how the article should be included in the summary.
The lead reviewers for Breast Cancer Treatment are: Fumiko Chino, MD (MD Anderson Cancer Center) Tarek Hijal, MD (McGill University Health Centre) Joseph L.
Pater, MD (NCIC-Clinical Trials Group) Carol Tweed, MD (Maryland Oncology Hematology) Any comments or questions about the summary content should be submitted to Cancer.gov through the NCI website'sEmail Us.
Do not contact the individual Board Members with questions or comments about the summaries.